Greg Herrema On Thermo Fisher Scientific Following Customers In Asia: An Interview With PharmAsia News
This article was originally published in PharmAsia News
Executive Summary
A new plant by Thermo Fisher Scientific Inc. to produce dry powder media used in the manufacture of biologic drugs in Singapore that matches the capacity and specs of its U.S.-based operations is another sign that Asia is on the roadmap for multinational biologics firms. Greg Herrema, president for biosciences at the company, sat down with PharmAsia News to talk about how the company sees the market in this region.